Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer.

Esnaola NF, Chaudhary UB, O'Brien P, Garrett-Mayer E, Camp ER, Thomas MB, Cole DJ, Montero AJ, Hoffman BJ, Romagnuolo J, Orwat KP, Marshall DT.

Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):837-44. doi: 10.1016/j.ijrobp.2013.12.030.

PMID:
24606850
[PubMed - indexed for MEDLINE]
2.

Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.

Wang J, Lu Z, Yeung BZ, Wientjes MG, Cole DJ, Au JL.

J Control Release. 2014 Mar 28;178:79-85. doi: 10.1016/j.jconrel.2014.01.012. Epub 2014 Jan 23.

PMID:
24462901
[PubMed - in process]
3.

The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis.

Johannesmeyer D, Smith V, Cole DJ, Esnaola NF, Camp ER.

Am J Surg. 2013 Sep;206(3):289-95. doi: 10.1016/j.amjsurg.2012.10.043. Epub 2013 Jun 24.

PMID:
23806824
[PubMed - indexed for MEDLINE]
4.

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.

Morse MA, Niedzwiecki D, Marshall JL, Garrett C, Chang DZ, Aklilu M, Crocenzi TS, Cole DJ, Dessureault S, Hobeika AC, Osada T, Onaitis M, Clary BM, Hsu D, Devi GR, Bulusu A, Annechiarico RP, Chadaram V, Clay TM, Lyerly HK.

Ann Surg. 2013 Dec;258(6):879-86. doi: 10.1097/SLA.0b013e318292919e.

PMID:
23657083
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.

Camp ER, Wang C, Little EC, Watson PM, Pirollo KF, Rait A, Cole DJ, Chang EH, Watson DK.

Cancer Gene Ther. 2013 Apr;20(4):222-8. doi: 10.1038/cgt.2013.9. Epub 2013 Mar 8.

PMID:
23470564
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice.

Mehrotra S, Al-Khami AA, Klarquist J, Husain S, Naga O, Eby JM, Murali AK, Lyons GE, Li M, Spivey ND, Norell H, Martins da Palma T, Onicescu G, Diaz-Montero CM, Garrett-Mayer E, Cole DJ, Le Poole IC, Nishimura MI.

J Immunol. 2012 Aug 15;189(4):1627-38. doi: 10.4049/jimmunol.1103271. Epub 2012 Jul 13.

PMID:
22798675
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Soluble IL-15/IL-15Rα complexes in human serum.

Cole DJ, Rubinstein MP.

Blood. 2012 Jul 5;120(1):1-2. doi: 10.1182/blood-2012-04-425306.

PMID:
22767572
[PubMed - indexed for MEDLINE]
Free Article
8.

Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

Rubinstein MP, Cloud CA, Garrett TE, Moore CJ, Schwartz KM, Johnson CB, Craig DH, Salem ML, Paulos CM, Cole DJ.

J Am Coll Surg. 2012 Apr;214(4):700-7; discussion 707-8. doi: 10.1016/j.jamcollsurg.2011.12.034. Epub 2012 Feb 22.

PMID:
22360982
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer.

Little EC, Wang C, Watson PM, Watson DK, Cole DJ, Camp ER.

J Surg Res. 2012 Aug;176(2):359-66. doi: 10.1016/j.jss.2011.10.025. Epub 2011 Nov 10.

PMID:
22221605
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Perioperative normothermia during major surgery: is it important?

Esnaola NF, Cole DJ.

Adv Surg. 2011;45:249-63. Review.

PMID:
21954692
[PubMed - indexed for MEDLINE]
11.

Normothermia to prevent surgical site infections after gastrointestinal surgery: holy grail or false idol?

Lehtinen SJ, Onicescu G, Kuhn KM, Cole DJ, Esnaola NF.

Ann Surg. 2010 Oct;252(4):696-704. doi: 10.1097/SLA.0b013e3181f6c2a9.

PMID:
20881777
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study.

Fisher CS, Cole DJ, Mitas M, Garrett-Meyer E, Metcalf JS, Gillanders WE, Mikhitarian K, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Baker MK.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:312-20. doi: 10.1245/s10434-010-1258-y. Epub 2010 Sep 19.

PMID:
20853052
[PubMed - indexed for MEDLINE]
13.

The Department of Surgery at the Medical University of South Carolina (1824-2010).

Crawford FA Jr, Cole DJ.

Am Surg. 2010 Sep;76(9):925-32. No abstract available.

PMID:
20836336
[PubMed - indexed for MEDLINE]
14.

Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.

Salem ML, Al-Khami AA, El-Naggar SA, Díaz-Montero CM, Chen Y, Cole DJ.

J Immunol. 2010 Feb 15;184(4):1737-47. doi: 10.4049/jimmunol.0902309. Epub 2010 Jan 18.

PMID:
20083664
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.

Salem ML, El-Naggar SA, Cole DJ.

Cell Immunol. 2010;261(2):134-43. doi: 10.1016/j.cellimm.2009.11.011. Epub 2009 Dec 5.

PMID:
20036354
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.

Salem ML, Cole DJ.

Cancer Immunol Immunother. 2010 Mar;59(3):341-53. doi: 10.1007/s00262-009-0792-6. Epub 2009 Nov 18. Review.

PMID:
19921513
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy.

Harper JL, Watkins JM, Zauls AJ, Wahlquist AE, Garrett-Mayer E, Baker MK, Cole DJ, Dragun AE, Jenrette JM 3rd.

Am J Surg. 2010 Feb;199(2):204-9. doi: 10.1016/j.amjsurg.2009.03.005. Epub 2009 Oct 17.

PMID:
19837390
[PubMed - indexed for MEDLINE]
18.

Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C).

Salem ML, Díaz-Montero CM, Al-Khami AA, El-Naggar SA, Naga O, Montero AJ, Khafagy A, Cole DJ.

J Immunol. 2009 Feb 15;182(4):2030-40. doi: 10.4049/jimmunol.0801829.

PMID:
19201856
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice.

Salem ML, Diaz-Montero CM, El-Naggar SA, Chen Y, Moussa O, Cole DJ.

Vaccine. 2009 Jan 22;27(4):549-57. doi: 10.1016/j.vaccine.2008.11.013. Epub 2008 Nov 21.

PMID:
19027047
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.

Watkins JM, Harper JL, Dragun AE, Ashenafi MS, Sinha D, Li J, Cole DJ, Jenrette JM 3rd.

Brachytherapy. 2008 Oct-Dec;7(4):305-9. doi: 10.1016/j.brachy.2008.07.001. Epub 2008 Sep 7.

PMID:
18778970
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk